Financhill
Buy
58

CHGCF Quote, Financials, Valuation and Earnings

Last price:
$40.21
Seasonality move :
7.55%
Day range:
$39.83 - $44.63
52-week range:
$29.75 - $52.22
Dividend yield:
1.22%
P/E ratio:
27.12x
P/S ratio:
9.23x
P/B ratio:
5.53x
Volume:
21.2K
Avg. volume:
10.3K
1-year change:
14.64%
Market cap:
$69.8B
Revenue:
$7.9B
EPS (TTM):
$1.56

Earnings Data

Next earnings date for CHGCF
Jan 30
2025
Most recent earnings per share
$0.45
Beat by $0.45
(Oct 25/2024)
Consensus Estimate
--
(Oct 25/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CHGCF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
10/25/2024 Q3 -- $2.1B $0.45 -- --
07/25/2024 Q2 -- $2B $0.44 -- --
04/24/2024 Q1 -- $1.6B $0.30 -- --
02/01/2024 Q4 -- $1.9B $0.38 -- --
09/30/2023 Q3 -- -- $0.33 -- --
07/27/2023 Q2 -- -- $0.37 -- --
04/27/2023 Q1 -- -- $0.34 -- --
12/31/2022 Q4 -- -- $0.44 -- --
10/24/2022 Q3 -- -- $0.30 -- --
07/21/2022 Q2 -- -- $0.34 -- --
04/25/2022 Q1 -- -- $0.69 -- --
02/03/2022 Q4 -- -- $0.53 -- --
10/22/2021 Q3 -- -- $0.47 -- --
07/26/2021 Q2 -- -- $0.39 -- --
04/22/2021 Q1 -- -- $0.27 -- --
02/04/2021 Q4 -- -- $0.30 -- --
10/22/2020 Q3 -- -- $0.34 -- --
07/27/2020 Q2 -- -- $0.29 -- --
04/23/2020 Q1 -- -- $0.29 -- --
01/30/2020 Q4 -- -- $0.22 -- --
10/24/2019 Q3 -- -- $0.27 -- --
07/25/2019 Q2 -- -- $0.19 -- --
04/24/2019 Q1 -- -- $0.19 -- --
01/31/2019 Q4 -- -- $0.12 -- --
10/24/2018 Q3 -- -- $0.12 -- --
07/26/2018 Q2 -- -- $0.12 -- --
04/24/2018 Q1 -- -- $0.16 -- --
02/01/2018 Q4 -- -- $0.08 -- --
10/25/2017 Q3 -- -- $0.12 -- --
07/27/2017 Q2 -- -- $0.10 -- --
04/25/2017 Q1 -- -- $0.10 -- --
02/01/2017 Q4 -- -- $0.06 -- --
10/25/2016 Q3 -- -- $0.07 -- --
07/21/2016 Q2 -- -- $0.10 -- --
03/31/2016 Q1 -- -- $0.08 -- --
12/31/2015 Q4 -- -- $0.07 -- --
10/22/2015 Q3 -- -- $0.09 -- --
07/24/2015 Q2 -- -- $0.08 -- --
04/22/2015 Q1 -- -- $0.07 -- --

Chugai Pharmaceutical Earnings Questions

  • How Much did Chugai Pharmaceutical Generate in Revenue Last Quarter?

    Chugai Pharmaceutical reported $2.1B worth of top line sales in its most recent quarter.

  • Did Chugai Pharmaceutical Beat Earnings Last Quarter?

    Chugai Pharmaceutical announced earnings per share of $0.45 which represents a beat of analyst forecast a -- per share.

  • Is Chugai Pharmaceutical Profitable?

    Chugai Pharmaceutical reported $1.6B that represents $0.95 per share over the last quarter.

  • What is the Analyst Consensus for Chugai Pharmaceutical EPS Next Year?

    Chugai Pharmaceutical's earnings are forecast to grow from $1.41 per share to -- per share next year representing an increase of --.

  • When is Chugai Pharmaceutical's Earnings Date?

    Chugai Pharmaceutical's next earnings date is January 30, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Philip Morris Stock Overvalued?
Is Philip Morris Stock Overvalued?

If there is one industry that can be termed truly…

What Quantum Stocks Should I Buy?
What Quantum Stocks Should I Buy?

The last several years have seen a series of tech…

Will Sirius XM Be a 10-Bagger Stock?
Will Sirius XM Be a 10-Bagger Stock?

Last year, Warren Buffett surprised practically everyone when he acquired…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
32
FTAI alert for Jan 22

FTAI Aviation [FTAI] is up 0.37% over the past day.

Sell
2
EDU alert for Jan 22

New Oriental Education & Technology Group [EDU] is down 0.41% over the past day.

Buy
51
GH alert for Jan 22

Guardant Health [GH] is up 6.78% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock